Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000630930 | SCV000751905 | uncertain significance | Fanconi anemia | 2022-09-01 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with lysine, which is basic and polar, at codon 113 of the FANCG protein (p.Arg113Lys). This variant is present in population databases (rs778894219, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with FANCG-related conditions. ClinVar contains an entry for this variant (Variation ID: 526405). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The lysine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Breakthrough Genomics, |
RCV004691961 | SCV005196358 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001835886 | SCV002077477 | uncertain significance | Fanconi anemia complementation group G | 2020-08-03 | no assertion criteria provided | clinical testing |